Shire PLC (NASDAQ:SHPG)

127.08
Delayed Data
As of Feb 23
 +1.03 / +0.82%
Today’s Change
123.73
Today|||52-Week Range
192.15
-18.08%
Year-to-Date
John Paulson Invests in Entertainment Stocks in 4th Quarter
Feb 21 / GuruFocus News - Paid Partner Content
Shire (SHPG) Q4 Earnings Beat, Immunology Franchise Strong
Feb 15 / Zacks.com - Paid Partner Content
John Paulson Invests in Entertainment in 4th Quarter
Feb 20 / GuruFocus News - Paid Partner Content
Shire (SHPG) to Report Q4 Earnings: What's in the Cards?
Feb 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close126.05
Today’s open127.56
Day’s range126.07 - 127.89
Volume920,306
Average volume (3 months)1,294,109
Market cap$38.6B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+1,014.78%
Earnings growth (this year)+3.90%
Earnings growth (next 5 years)+8.03%
Revenue growth (last year)+35.39%
P/E ratio9.1
Price/Sales3.08
Price/Book1.06

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+8.31+5.27%
REGNRegeneron Pharmaceut...+8.04+2.55%
BAXBaxter International...+0.93+1.38%
ALXNAlexion Pharmaceutic...+4.34+3.79%
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateMay 1, 2018
EPS forecast (this quarter)$3.84
Annual revenue (last year)$15.3B
Annual profit (last year)$4.3B
Net profit margin28.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Medical Officer
Howard Mayer
Corporate headquarters
Dublin, Dublin

Forecasts